Mechanistic role of obesity in benzo(a)pyrene-initiated cancer
肥胖在苯并(a)芘引发的癌症中的机制作用
基本信息
- 批准号:10214618
- 负责人:
- 金额:$ 37.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-13 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:4T1AcuteAdipose tissueAgarAromatic Polycyclic HydrocarbonsAryl Hydrocarbon ReceptorBenzo(a)pyreneBreast Cancer Risk FactorBreast CarcinogenesisBreast Epithelial CellsCancer BurdenCarcinogensCellsCentral obesityChronicCultured CellsDNA DamageDataEPHX1 geneEnzymesEpoxy CompoundsEtiologyExposure toFGF2 geneFGFR1 geneFibroblast Growth Factor Receptor 2FibroblastsGene ExpressionGenetic TranscriptionGrowthGrowth FactorHigh Fat DietHumanHydrolaseIn VitroInbred BALB C MiceIndividualLeadMCF10A cellsMalignant - descriptorMalignant NeoplasmsMammary TumorigenesisMass Spectrum AnalysisMeasuresMediatingMetabolic PathwayMetabolismModelingMusNatureObesityOutcomes ResearchPathway interactionsPhaseProcessReceptor ActivationReceptor SignalingResearchRiskRoleSignal TransductionTestingTimeTissuesUp-RegulationVisceralWorkadductcarcinogenesiscarcinogenicitycell transformationdisorder riskfeedingfollow-upimaging approachin vivoinhibitor/antagonistmalignant breast neoplasmmammarymammary epitheliummultiphoton imagingneutralizing antibodynoveloverexpressionreceptorreceptor expressionreceptor upregulationrelease factortranscriptome sequencingtumortumorigenesis
项目摘要
Project Summary
This R01 is about our discovery of a surprising and unexpected way in which adipose tissue increases the
vulnerability of mammary epithelial cells to benzo(a)pyrene (BaP), a Group I-classified carcinogen, by inducing
the aryl hydrocarbon receptor (AhR) protein. Upregulation of AhR expression and transcription is important in
several, if not all, stages of malignant transformation. In particular, AhR is upregulated in human breast cancer.
A major gap in AhR research is the nature of the signals that drive AhR induction and activation in breast
carcinogenesis. Until now, no one might have expected that in the search for the unknown activators and
inducers of AhR, that secretions from visceral adipose tissue (VAT) would be among them. Remarkably, our
data shows that factors secreted from VAT can induce AhR in mammary epithelial cells, and AhR is also induced
in mammary tissues of mice fed a high-fat diet. Our preliminary data also strongly suggest: 1) BaP and secretions
from VAT, such as fibroblast growth factor-2 (FGF2), synergize to cause DNA damage and accelerated
transformation of human mammary epithelial cells; and 2) AhR is a critical control point for BaP bioactivation in
this synergistic process. Our central hypothesis is that factors secreted from human VAT will potentiate BaP
metabolism by inducing AhR, resulting in increased carcinogenic metabolites (e.g. BPDE) and DNA damage,
two well-known contributors to malignant transformation of human mammary epithelial cells. We will test this
hypothesis in connection with human breast cancer. In aim 1, we will determine the impact of factors released
from VAT on BaP metabolism and DNA damage in vitro. We will also determine what is in VAT that effects BaP
metabolism and induces AhR. In aim 2, we will determine for the first time in vivo the impact of high-fat diet
feeding on AhR-mediated BaP metabolism, DNA damage and mammary tumorigenesis using both acute and
chronic exposures to BaP. For both aims, we will determine the role of FGFR1 signaling, the primary receptor
for FGF2, on the AhR activation and metabolism of BaP using a FGFR1 inhibitor and a novel orthotopic model
of FGFR1-driven mammary tumorigenesis. The expected outcomes of this research will be to identify the
mechanisms and metabolic pathways by which BaP interacts with factors released from VAT in promoting DNA
damage and breast cancer. BaP metabolites will be analyzed using a novel multiphoton imaging approach.
Elucidating the unexpected and surprising connection between factors from human visceral adipose tissues and
the bioactivation benzo(a)pyrene (BaP) will be a major advance in understanding why obesity heightens the risk
of breast cancer.
项目摘要
这个R 01是关于我们发现了一个令人惊讶和意想不到的方式,脂肪组织增加了
乳腺上皮细胞对苯并(a)芘(BaP)(一种I类致癌物)的脆弱性,通过诱导
芳香烃受体(AhR)蛋白。AhR表达和转录的上调在
恶性转化的几个阶段特别是,AhR在人乳腺癌中上调。
AhR研究的一个主要空白是驱动乳腺中AhR诱导和激活的信号的性质。
致癌作用到目前为止,没有人会想到,在寻找未知的激活剂和
AhR的诱导物,内脏脂肪组织(VAT)分泌物将在其中。值得注意的是,我们
数据显示,VAT分泌的因子可以诱导乳腺上皮细胞中的AhR,并且AhR也被诱导
在高脂饮食小鼠的乳腺组织中。我们的初步数据还有力地表明:1)BaP和分泌物
从增值税,如成纤维细胞生长因子-2(FGF 2),协同作用,造成DNA损伤和加速
人乳腺上皮细胞的转化;和2)AhR是BaP生物活化的关键控制点
这个协同过程。我们的中心假设是,从人类VAT分泌的因子将增强BaP
通过诱导AhR代谢,导致致癌代谢物(如BPDE)和DNA损伤增加,
两种众所周知的导致人乳腺上皮细胞恶性转化的因素。我们将测试这个
与人类乳腺癌有关的假说。在目标1中,我们将确定释放的因素的影响
VAT对BaP代谢和DNA损伤的影响。我们还将确定增值税中影响BaP的内容
代谢并诱导AhR。在aim 2中,我们将首次在体内确定高脂饮食的影响
以AhR介导的BaP代谢、DNA损伤和乳腺肿瘤发生为基础,
长期接触苯并(a)芘对于这两个目标,我们将确定FGFR 1信号传导的作用,
对于FGF 2,使用FGFR 1抑制剂和新型原位模型对AhR活化和BaP代谢的影响
FGFR 1驱动的乳腺肿瘤发生。这项研究的预期结果将是确定
BaP与VAT释放的因子相互作用促进DNA合成的机制和代谢途径
损伤和乳腺癌。BaP代谢物将使用新的多光子成像方法进行分析。
阐明了来自人类内脏脂肪组织的因子与
苯并(a)芘(BaP)的生物活性将是理解肥胖为什么会增加风险的一个重大进展。
乳腺癌
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jamie J Bernard其他文献
The Contribution of Oncogenic RAS Mutations in Obesity-Associated Multiple Myeloma
- DOI:
10.1182/blood-2024-205615 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Jonathan D Diedrich;Samantha A Musso;Matthew Pianko;Jamie J Bernard - 通讯作者:
Jamie J Bernard
Jamie J Bernard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jamie J Bernard', 18)}}的其他基金
Mechanistic role of obesity in benzo(a)pyrene-initiated cancer
肥胖在苯并(a)芘引发的癌症中的机制作用
- 批准号:
10621721 - 财政年份:2020
- 资助金额:
$ 37.87万 - 项目类别:
First Time Summer Research Experience in Environmental Health Sciences
环境健康科学的首次夏季研究经历
- 批准号:
10312813 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
First Time Summer Research Experience in Environmental Health Sciences
环境健康科学的首次夏季研究经历
- 批准号:
10529286 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
Research Experience and Training Coordination Core
研究经验和培训协调核心
- 批准号:
10353540 - 财政年份:1997
- 资助金额:
$ 37.87万 - 项目类别:
相似海外基金
Adipose tissue stem cells and its extracellular vesicles could attenuate acute lung injury in a newborn porcine model of respiratory distress and ventilatory induced lung injury.
脂肪组织干细胞及其细胞外囊泡可以减轻新生猪呼吸窘迫和通气引起的肺损伤模型中的急性肺损伤。
- 批准号:
22K07874 - 财政年份:2022
- 资助金额:
$ 37.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Acute and Chronic Effects of Adipose Tissue Growth on Cellular and Metabolic Processes
脂肪组织生长对细胞和代谢过程的急性和慢性影响
- 批准号:
418323-2012 - 财政年份:2019
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Grants Program - Individual
Acute and Chronic Effects of Adipose Tissue Growth on Cellular and Metabolic Processes
脂肪组织生长对细胞和代谢过程的急性和慢性影响
- 批准号:
418323-2012 - 财政年份:2018
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Grants Program - Individual
Acute and Chronic Effects of Adipose Tissue Growth on Cellular and Metabolic Processes
脂肪组织生长对细胞和代谢过程的急性和慢性影响
- 批准号:
418323-2012 - 财政年份:2017
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Grants Program - Individual
Acute and Chronic Effects of Adipose Tissue Growth on Cellular and Metabolic Processes
脂肪组织生长对细胞和代谢过程的急性和慢性影响
- 批准号:
418323-2012 - 财政年份:2016
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Grants Program - Individual
Acute and Chronic Effects of Adipose Tissue Growth on Cellular and Metabolic Processes
脂肪组织生长对细胞和代谢过程的急性和慢性影响
- 批准号:
418323-2012 - 财政年份:2015
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Grants Program - Individual
Acute and Chronic Effects of Adipose Tissue Growth on Cellular and Metabolic Processes
脂肪组织生长对细胞和代谢过程的急性和慢性影响
- 批准号:
418323-2012 - 财政年份:2014
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Grants Program - Individual
Acute and Chronic Effects of Adipose Tissue Growth on Cellular and Metabolic Processes
脂肪组织生长对细胞和代谢过程的急性和慢性影响
- 批准号:
418323-2012 - 财政年份:2013
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Grants Program - Individual
Adipose Tissue-Derived Stem Cells Suppress Acute Cellular Rejection by TSG-6 and CD44 interaction in Rat Kidney Transplantation.
脂肪组织干细胞在大鼠肾移植中通过 TSG-6 和 CD44 相互作用抑制急性细胞排斥。
- 批准号:
25861419 - 财政年份:2013
- 资助金额:
$ 37.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Acute and Chronic Effects of Adipose Tissue Growth on Cellular and Metabolic Processes
脂肪组织生长对细胞和代谢过程的急性和慢性影响
- 批准号:
418323-2012 - 财政年份:2012
- 资助金额:
$ 37.87万 - 项目类别:
Discovery Grants Program - Individual